SCHEDULE AT A GLANCE

Excipient World 2019 Schedule at a glance

Note: Below schedule was published on March 4th, 2019 and may be updated with additional items.

2019 Conference Tracks:
F = Formulation & Technology Advancements
Q = Quality & Regulatory
S = Supply Chain
E = Emerging Trends

Note: All times are Eastern Standard Time
Onsite Program Registration is Open from 7:30 AM - 5:00 PM on Monday

Monday, May 6
RoomTimeAzalea 1Azalea 2Azalea 3Magnolia 1
9:00 AMto12:00 PMEssential new IPEC Guides: What everyone should know!Chris Moreton - FinnBrit Consulting,
Luc Sergile - Eli Lilly and Company,
Katherine Ulman - KLU Consulting,
Bretta Lichtenhan - Millipore Sigma
F Q S E
Coming soon!Data IntegrityJaneen Skutnik Wilkinson - Biogen
Dale Carter - Evonik
Q S
Drug Development
(Part 1 of 2)
Dr. Nigel Langley - BASF
Dr. Ali Rajabi-Siahboomi - Colorcon
F Q S
12:00 PMto1:00 PMNetworking Lunch (Camellia 3-4)
1:00 PMto4:00 PMRegulatory and GMP Considerations for Inactive Ingredients in FDA Regulated ProductsMeera Raghuram - Lubrizol Advanced Materials
Katherine Ulman - KLU Consulting,
Irwin Silverstein - IBS Consulting in Quality,
Luke Grocholl - Millipore Sigma
F
The Importance of Excipients in Continuous ManufacturingDr. Brian Carlin - DFE Pharma
Heather Sturtevant - J&J Consumer Healthcare
Phyllis Walsh - Merck & Company, Inc.
Dr. Katie Hewlett - Dupont
F Q E
The Facts about Titanium Dioxide (E171) Safety – A Debacle in FranceDavid Schoneker - Colorcon
Bretta Lichtenhan - Millipore Sigma
F Q
call-to-action-tio2-excipient-world-conference-program
Drug Development
(Part 2 of 2)
Dr. Nigel Langley - BASF
Dr. Ali Rajabi-Siahboomi - Colorcon
F Q S
1:00 PMto6:00 PMExhibitor Move-in & Booth Set-up (Riverview Ballroom)

 

Onsite Program Registration is Open from 7:00 AM - 5:00 PM on Tuesday (Riverview Foyer)
Tuesday, May 7, 2019
7:00 AMto8:00 AMCoffee Service (Riverview Foyer)
8:00 AMto9:00 AMWelcome Speech & Keynote 1: Civica Rx a Disruptive ForceMartin Van Trieste - Civica RxQ S E
9:00 AMto9:30 AMCoffee & Networking Break (Riverview Ballroom)
RoomTimeRiverview BRiverview 4-5Eastern Shore 2
9:30 AMto10:30 AMNeed for Science and Risk Based Excipients Specification SettingSunil Kumar - DFE PharmaF QChallenges Related to Stability of Excipients and their Supply ChainPriscilla Zawislak - Dow DuPontQ SExcipients: Appropriate Selection, Sourcing, Testing and Filing in a Global EnvironmentMark Wiggins - Global Pharmacopoeia Solutions LLCQ
10:30 AMto11:00 AMCoffee & Networking Break (Riverview Ballroom)
11:00 AMto12:00 PMExcipient Risk Assessment: Launch of the IPEC/PDA Technical ReportJaneen Skutnik Wilkinson - BiogenQ SExcipients and Manufacturing Technologies Addressing Future NeedsDr. Dieter Lubda - Merck KGaAF EComing soon!Speaker from GADA - Generic Animal Drug Alliance
12:00 PMto1:00 PMNetworking Lunch (Eastern Shore 1)
1:30 PMto2:30 PMExcipient Regulation Update in ChinaDavid Schoneker - ColorconQ
Excipient World Conference Program
A Convenient Formulation of Orodispersible Mini-Tablets for Pediatric AdministrationDr. Michael Black - Beneo/ChemroyFUtilization of Quality By Design
Principles to Define Formulation Best Practices for a Direct Compression Excipient
Dr. Katie Hewlett - DupontF Q E
2:30 PMto3:00 PMCoffee & Networking Break (Riverview Ballroom)
3:00 PMto4:00 PMKeynote 2: Quality CultureCarmelo Rosa - FDA
4:00 PMto4:15 PMCoffee & Networking Break (Riverview Ballroom)
4:15 PMto5:00 PMSpeakers Roundtable (Riverview B)
5:00 PMExhibits Close
5:00 PMto7:00 PMExcipient World Cocktail Reception (Riverview Ballroom)

 

Onsite Program Registration is Open from 7:00 AM - 5:00 PM on Wednesday (Riverview Foyer)
Wednesday, May 8
7:00 AMto8:00 AMCoffee Service (Riverview Foyer)
8:00 AMto9:00 AM Keynote 3 (Riverview B): Advancing Future Drug Development Science -
Who (patient populations), What (formulations) and How (emerging methods for manufacture)?
Member(s) of IQ Drug Product Leadership GroupF E
9:00 AMto9:30 AMCoffee & Networking Break (Riverview Ballroom)
RoomTimeRiverview BRiverview 4-5Eastern Shore 2
9:30 AMto10:30 AMInnovative Approaches to Taste-
Masking Bitter Drugs for Pediatric Patients
Dr. Nigel Langley - BASFF
The Value of Setting Meaningful Compendial Specifications for Excipients – a USP PerspectiveCatherine Sheehan - USPQ SGlobal Substance Registration System (GSRS) and the Impact on the Inactive Ingredient Database (IID)Susan Zuk - FDA
10:30 AMto11:00 AMCoffee & Networking Break (Riverview Ballroom)
11:00 AMto12:00 PMThe Value of High-Functionality Excipients in Continuous ManufacturingAnthony Carpanzano - JRSF Q EPreservation of Products for the Pharmaceutical IndustryDr. Nelson Ayala - Unicus Pharmaceuticals, LLCF Q SBinders for DC Excipients:
A Comparative Study
Carolina Diaz-Quijano - OmyaF E
12:00 PMto1:00 PMNetworking Lunch (Eastern Shore 1)
1:30 PMto2:30 PMHow Excipient Supplier Certification is Adding Value to the Pharma IndustryDale Carter - EvonikQ SInfluence of Excipients and Design Considerations in Formulating a Direct Compression ODT Dosage FormEvonne Brennan - IMCD US PharmaFAtypical Actives:
Challenges for Drug Product Manufacturers
Jennifer Putnam - PerrigoQ
2:30 PMto3:00 PMCoffee & Networking Break (Riverview Ballroom)
3:00 PMto4:00 PMComing soon!Time is of Essence: Coprocessed Multifunctional ExcipientsChintan Shah - Innophos IncF EFormulation and Laboratory Screening Processes and the Reality of 'Easy to Swallow' PharmaceuticalsRita Steffenino - ColorconF Q
4:00 PMto4:15 PMCoffee & Networking Break (Riverview Ballroom)
4:15 PMto5:00 PMKeynote 4 (Riverview B): Good Supply Practices: Practical Solutions You Can Implement TodayMarla Phillips - Xavier UniversityS
5:00 PMExhibits Close
5:00 PMto6:00 PMExcipient World Cocktail Reception (Riverview Ballroom)